Modified lecithin-cholesterol acyltransferase enzymes

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 9/10 (2006.01) A61K 38/45 (2006.01)

Patent

CA 2694590

The invention provides compounds, pharmaceutical compositions and methods for treating atherosclerosis, coronary heart disease, thrombosis, and for decreasing or prevention of accumulation of cholesterol in a subject by modifying LCAT polypeptide.

L'invention concerne des composés, des compositions pharmaceutiques et des procédés pour traiter l'athérosclérose, une maladie coronarienne, une thrombose et pour diminuer ou empêcher l'accumulation de cholestérol chez un sujet par modification du polypeptide LCAT

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modified lecithin-cholesterol acyltransferase enzymes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified lecithin-cholesterol acyltransferase enzymes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified lecithin-cholesterol acyltransferase enzymes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1699314

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.